David R. Soto-Pantoja, Ph.D.
Affiliations: | 2008 | Wake Forest University, Winston-Salem, NC, United States |
Area:
Oncology, Cell Biology, Molecular BiologyGoogle:
"David Soto-Pantoja"Parents
Sign in to add mentor| E Ann Tallant | grad student | 2008 | Wake Forest | |
| (Angiotensin-(1-7): A novel small molecule for the targeted treatment of triple negative breast cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mackert JD, Stirling ER, Wilson AS, et al. (2023) Anti-CD47 immunotherapy as a therapeutic strategy for the treatment of breast cancer brain metastasis. Biorxiv : the Preprint Server For Biology |
| Klepin HD, Tooze JA, Bitting RL, et al. (2023) Study design and methods for the pilot study of muscadine grape extract supplement to improve fatigue among older adult cancer survivors (FOCUS) trial. Journal of Geriatric Oncology. 101478 |
| Bronson SM, Westwood B, Cook KL, et al. (2022) Discrete Correlation Summation Clustering Reveals Differential Regulation of Liver Metabolism by Thrombospondin-1 in Low-Fat and High-Fat Diet-Fed Mice. Metabolites. 12 |
| Bawaneh A, Wilson AS, Levi N, et al. (2022) Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer. Cancers. 14 |
| Newman TM, Clear KYJ, Wilson AS, et al. (2022) Early life dietary exposures mediate persistent shifts in the gut microbiome and visceral fat metabolism. American Journal of Physiology. Cell Physiology |
| Shelkey E, Oommen D, Stirling ER, et al. (2022) Immuno-reactive cancer organoid model to assess effects of the microbiome on cancer immunotherapy. Scientific Reports. 12: 9983 |
| Ramirez MU, Clear KYJ, Cornelius Z, et al. (2022) Diet impacts triple-negative breast cancer growth, metastatic potential, chemotherapy responsiveness, and doxorubicin-mediated cardiac dysfunction. Physiological Reports. 10: e15192 |
| Triozzi PL, Stirling ER, Song Q, et al. (2022) Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti-PD-1 Immune Checkpoint Blockade. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 28: 1192-1202 |
| Stirling ER, Bronson SM, Mackert JD, et al. (2022) Metabolic Implications of Immune Checkpoint Proteins in Cancer. Cells. 11 |
| Arnone AA, Cline JM, Soto-Pantoja DR, et al. (2021) Investigating the role of endogenous estrogens, hormone replacement therapy, and blockade of estrogen receptor-α activity on breast metabolic signaling. Breast Cancer Research and Treatment |